Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Hires New CEO; TIGR Taps New VP; Accelrys Names New Consortium Members; James Watson Gets New Appointment; and Others

The Indiana Centers for Applied Protein Sciences has hired Jeffrey Billig as its new chief financial officer. INCAPS is a fee-for-service contract research organization that provides proteomic technology validation and protein analysis services for academic and private sector clients.


Billig comes to INCAPS from the Mitchel Group, where he was vice president and chief financial officer. He received his MS in management from the PurdueUniversity Krannert School of Business.

Kalypsys has hired Rodney Turner to lead worldwide sales efforts for the company's automated drug discovery systems, the firm said this week. He will oversee the sales and marketing efforts for the full range of Kalypsys automated systems to academic and government institutions and   pharmaceutical customers in the United Statesand, for the first time, Europeand Asia.


Turner comes to Kalypsys from RTK Group, a life science strategic consultancy based in San Francisco, where he was a partner and co-founder. Previously, he was vice president of business development for Fluidigm.

NuGen Technologies has appointed Elizabeth Hutt chief executive officer, effective Nov. 1. She replaces Elizabeth Davila, who will remain a member of the company's board of directors.


Hutt, previously NuGEN's vice president of commercial operations, will "lead the company in the development and commercialization of its ... nucleic acid amplification and detection technologies," the firm said this week.


As part of the changes, Anne Kopf-Sill, vice president of product development, has been promoted to senior vice president of product development and operations.


Prior to joining NuGen, Hutt was vice president of sales and service for North Americaand Pacific Rimat Tripos. She has held US and European sales management positions with Affymetrix. She holds a BA in chemistry from Michigan State University and an MS in business administration from Central Michigan University.

Accelrys has added seven new members to the Accelrys Nanotechnology Consortium, a collection of individuals from industry, government, and academia aimed at creating software that "speed up the design of nanomaterials and nanodevices," the company said. The new members include: KyotoUniversity, Millennium Chemicals, R.J. Mears, CSIC of Spain, and PPG Industries.

The Institute for Genomic Research has tapped Eric Eisenstadt as vice president for research libraries, the lab said this week. Eisenstadt, whose background is in microbial physiology and genetics, will help TIGR "increasingly participate in the development and application of new tools to capture and analyze microbial genomes isolated directly from complex mixtures of organisms in ecological systems, such as the human gut, soil, or marine habitats."


He comes to TIGR from the Defense Advanced Research Projects Agency's Defense Sciences Office, where he was a program manager, and, before that, the Office of Naval Research's Biological Science and Technology Division.

Charis Eu Li Eng has been named chair of the Genomic Medicine Institute at The Cleveland Clinic Lerner Research Institute effective Sept. 1. She will oversee genomic research for all of Lerner's programs, including those in neuroscience, cancer, cardiovascular medicine, musculoskeletal issues, and digestive disease.


Eng comes to the Clinic from Ohio State University, where she was director of the Clinical Cancer Genetics Program and the Division of Human Genetics. She has an MD and PhD from the Universityof Chicago.

James Watson has been appointed as a special advisor to the board of Seed Media Group.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.